Literature DB >> 8869846

Epidemiology, control and treatment of multidrug-resistant tuberculosis.

P Chaulet1, M Raviglione, F Bustreo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8869846     DOI： 10.2165/00003495-199600522-00021

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  12 in total

1.  Human bioavailability studies.

Authors:  G Acocella
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1989-03

2.  A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.

Authors: 
Journal:  Tubercle       Date:  1974-03

3.  Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1988-05

4.  [Possible causes of the failure of the treatment of pulmonary tuberculosis ; how to avoid them].

Authors:  J Crofton
Journal:  Bull Int Union Tuberc       Date:  1980 Sep-Dec

5.  Surveillance of drug resistance for tuberculosis control: why and how?

Authors:  P Chaulet; F Boulahbal; J Grosset
Journal:  Tuber Lung Dis       Date:  1995-12

Review 6.  Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease.

Authors:  D L Cohn; F Bustreo; M C Raviglione
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

7.  The supply of antituberculosis drugs and national drugs policies.

Authors:  P Chaulet
Journal:  Tuber Lung Dis       Date:  1992-10

8.  [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].

Authors:  M Berkani; P Chaulet; J H Darbyshire; A Nunn; W Fox
Journal:  Rev Mal Respir       Date:  1986       Impact factor: 0.622

9.  [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].

Authors:  L Mazouni; M Tazir; F Boulahbal; P Chaulet
Journal:  Rev Mal Respir       Date:  1985       Impact factor: 0.622

10.  [Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiothérapie de la Tuberculose].

Authors:  P Chaulet; F Boulahbal
Journal:  Tuber Lung Dis       Date:  1995-10
View more
  1 in total

1.  Fatal tuberculous meningitis caused by immune restoration disease.

Authors:  Hagen B Huttner; Rainer Kollmar; Andreas Hug; Fabian Meisel; Bodo Kress; Stefan Schwab
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.